"From routine appointments to emergency services, it’s important to get the care you need—when you need it. But we understand you may be delaying your health needs over concerns about safety. At Mount Sinai, our doctors, nurses, and staff members are working continuously to ensure your safety so that you don't have to put your health on hold."

During the past decade, Mount Sinai West conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 35 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 23 clinical trials were completed. i.e. 59% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai West" #1 sponsor was "National Cancer Institute (NCI)" with 29 trials, followed by "Icahn School of Medicine at Mount Sinai" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "St. Luke's-Roosevelt Hospital Center" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai West" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai West" are "Breast Cancer" (6 trials), "Invasive Breast Carcinoma" (6 trials), "Breast Adenocarcinoma" (4 trials), "Pregnancy" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Mount Sinai West" in a lesser frequency.

Most popular intervention types in "Mount Sinai West" are "Drug" (68 trials), "Other" (49 trials), "Radiation" (23 trials), "Procedure" (22 trials) and "Biological" (21 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (22 trials), "Laboratory Biomarker Analysis" (18 trials), "Paclitaxel" (14 trials), "Carboplatin" (13 trials) and "Questionnaire Administration" (11 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai West" are 83 trials for "All" genders, 27 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mount Sinai West". undefined are not yet recruiting, 25 are recruiting, 38 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 23 completed trials in Mount Sinai West, 3 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai West, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 30 trials that are defined as “Not Applicable".